BioAtla
Latest round
- Series D
Last raised
- Jun 2020
Total raised
- $73M
Investors
- 6
About BioAtla
BioAtla, Inc.Founded in 2007, BioAtla, Inc. operates from San Diego, US, specializing in the development of conditionally active biologics for oncology.BioAtla specializes in the development of conditionally active biologics (CABs), a class of therapeutics designed to enhance the efficacy and safety of cancer treatments. Their technology enables the creation of antibodies and other biologics activated by specific physiological conditions, targeting the tumor microenvironment for improved therapeutic indices.02 mn. The company is targeting the expansion of its product offerings and aims to enter new geographic markets to enhance its operational footprint in the biopharmaceutical sector.
Who invested in BioAtla
6 investors across 1 round
See all investors in BioAtla
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jun 10, 2020
Amount
$73M
Investors
Questions about BioAtla
Who invested in BioAtla?
BioAtla has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioAtla raised?
BioAtla has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioAtla last raise money?
BioAtla's most recent round on record is a Series D, in Jun 2020.
What does BioAtla do?
BioAtla is a biotechnology company.
Where is BioAtla headquartered?
BioAtla is headquartered in San Diego, US.
Which VCs invest in companies like BioAtla?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BioAtla's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like BioAtla? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.